Novavax and UK Government Announce Collaboration and Purchase Agreement for Novavax’ COVID-19 Vaccine Candidate

UK government to purchase 60 million doses of NVX-CoV2373
Novavax to partner with FUJIFILM Diosynth Biotechnologies to manufacture antigen component of NVX-CoV2373 in the UKNovavax and UK government to collaborate on Phase 3 clinical trial in UK commencing in the third quarter of this yearNovavax intends to
Bay Street News